MULTIPLE DRUG DETECTION IN FINGER PRICK BLOOD

Award Information
Agency:
Department of Health and Human Services
Amount:
$50,000.00
Program:
SBIR
Contract:
N/A
Solitcitation Year:
N/A
Solicitation Number:
N/A
Branch:
N/A
Award Year:
1991
Phase:
Phase I
Agency Tracking Number:
16807
Solicitation Topic Code:
N/A
Small Business Information
Bio-metric Systems Inc
9924 W 74th St, Eden Prairie, MN, 55344
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 Melvin J Swansen
 (612) 829-2700
Business Contact
Phone: () -
Research Institution
N/A
Abstract
WE WILL DEVELOP AND DEMONSTRATE THE FEASIBILITY OF AN ENZYMEIMMUNOASSAY FORMAT CAPABLE OF SIMULTANEOUSLY DETECTING AND IDENTIFYING ANY ONE OR MORE OF MULTIPLE DRUGS IN BLOOD FROM A FINGER PRICK. THE EVENTUAL GOAL IS TO DEVELOP A SCREENINGTEST DEVICE HAVING A BUILT-IN SAMPLER WHICH WOULD ALLOW THE USER TO TOUCH THE DEVICE ONTO A DROP OF BLOOD FROM A FINGER PRICK, TURN THE DEVICE OVER AND TAP IT TO INTRODUCE THE SAMPLE, PLACE THE DEVICE INTO A DEVELOPING SOLUTION, WAIT FOR A FEW MINUTES AND OBSERVE THE RESULTS. ANY DESIGNATED BANDS HAVING COLOR WOULD INDICATE THE PRESENCE OF THE CORRESPONDING DRUG. THE SPECIFIC GOAL OF THE PHASE I PROJECT IS TO DEVELOP THE TECHNIQUE, USING A SIMPLER APPARATUS, AND TO DEMONSTRATE THAT ANY COMBINATION OF COCAINE, MORPHINE AND PHENCYCLIDINE CAN BE IDENTIFIED IN A SMALL BLOOD SAMPLE, EACH AT 20 NANOGRAMS/ML OR GREATER CONCENTRATIONS. WE WILL DEVELOP AND DEMONSTRATE THE FEASIBILITY OF AN ENZYMEIMMUNOASSAY FORMAT CAPABLE OF SIMULTANEOUSLY DETECTING AND IDENTIFYING ANY ONE OR MORE OF MULTIPLE DRUGS IN BLOOD FROM A FINGER PRICK. THE EVENTUAL GOAL IS TO DEVELOP A SCREENINGTEST DEVICE HAVING A BUILT-IN SAMPLER WHICH WOULD ALLOW THE USER TO TOUCH THE DEVICE ONTO A DROP OF BLOOD FROM A FINGER PRICK, TURN THE DEVICE OVER AND TAP IT TO INTRODUCE THE SAMPLE, PLACE THE DEVICE INTO A DEVELOPING SOLUTION, WAIT FOR A FEW MINUTES AND OBSERVE THE RESULTS. ANY DESIGNATED BANDS HAVING COLOR WOULD INDICATE THE PRESENCE OF THE CORRESPONDING DRUG. THE SPECIFIC GOAL OF THE PHASE I PROJECT IS TO DEVELOP THE TECHNIQUE, USING A SIMPLER APPARATUS, AND TO DEMONSTRATE THAT ANY COMBINATION OF COCAINE, MORPHINE AND PHENCYCLIDINE CAN BE IDENTIFIED IN A SMALL BLOOD SAMPLE, EACH AT 20 NANOGRAMS/ML OR GREATER CONCENTRATIONS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government